Concepedia

Daniel Harari

DH

Statistics

Publications

19

Citations

2K

H-Index

17

Active since

1997

Affiliations

Weizmann Institute of Science(Current)

Ben-Gurion University of the Negev

Merck Serono S.A. (Switzerland)

Institut Pasteur

Monash University

Daniel Harari is an author at Weizmann Institute of Science specializing in life sciences, signal transduction, and molecular biology.

ORCID

Publications per year

1997–2022

19

Publications

19

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

Jiří Zahradník, Shir Marciano, Maya Shemesh et al. · Nature Microbiology · 2021 · 421 citations · Full text

, , +9

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase

Daniel Harari, Eldad Tzahar, Jan E. Romano et al. · Oncogene · 1999 · 315 citations

, , +12

Hsp90 Recognizes a Common Surface on Client Kinases

Ami Citri, Daniel Harari, Galit Shohat-Ophir et al. · Journal of Biological Chemistry · 2006 · 220 citations · Full text

, , +14

Ligand‐Independent Degradation of Epidermal Growth Factor Receptor Involves Receptor Ubiquitylation and Hgs, an Adaptor Whose Ubiquitin‐Interacting Motif Targets Ubiquitylation by Nedd4

Menachem Katz, Keren Shtiegman, Pazit Tal‐Or et al. · Traffic · 2002 · 147 citations · Full text

, , +17

SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

Maya Shemesh, Turgut E. Aktepe, Joshua M. Deerain et al. · PLoS Pathogens · 2021 · 145 citations · Full text

, , +17

1–5 of 19